Contributor

Emmanuel Aisabokhae

Emmanuel Aisabokhae

Principal, Healthcare & Life Sciences

Fast Pharma: The Cost of Coming in Second in Clinical Trials

Fast Pharma: The Cost of Coming in Second in Clinical Trials

Modern biopharma is shifting from a marathon to a sprint — where second place costs billions. 

READ ARTICLE →

11 min read

May 2026

Healthcare & Life Sciences

Research & Development

Strategy

Putting Patients First: The Key to Long-Term Pharma Success

Putting Patients First: The Key to Long-Term Pharma Success

The business case for truly patient-led pharma growth

READ ARTICLE →

17 min read

Apr 2024

Healthcare & Life Sciences